MANUFACTURER ABUSE OF IDE REGS TO MARKET DEVICES
This article was originally published in The Gray Sheet
Executive Summary
MANUFACTURER ABUSE OF IDE REGS TO MARKET DEVICES is being probed by the HHS Inspector General's office, according to an updated version of the IG work plan for fiscal year 1995. Under the audit, which was requested by FDA Center for Devices and Radiological Health Director Bruce Burlington, the IG is looking at whether companies are using investigational device exemptions as cover for essentially marketing the products. FDA is concerned the practice may be "pervasive" in the industry, according to agency staffers.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.